rs150001738
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBS1_Supporting
The NM_014425.5(INVS):āc.2056A>Gā(p.Arg686Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000511 in 1,613,478 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_014425.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
INVS | NM_014425.5 | c.2056A>G | p.Arg686Gly | missense_variant | 13/17 | ENST00000262457.7 | NP_055240.2 | |
INVS | NM_001318381.2 | c.1768A>G | p.Arg590Gly | missense_variant | 14/18 | NP_001305310.1 | ||
INVS | NM_001318382.2 | c.1078A>G | p.Arg360Gly | missense_variant | 13/17 | NP_001305311.1 | ||
INVS | NR_134606.2 | n.2254A>G | non_coding_transcript_exon_variant | 13/17 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
INVS | ENST00000262457.7 | c.2056A>G | p.Arg686Gly | missense_variant | 13/17 | 1 | NM_014425.5 | ENSP00000262457 | A2 | |
INVS | ENST00000262456.6 | c.2056A>G | p.Arg686Gly | missense_variant | 13/18 | 5 | ENSP00000262456 | P4 |
Frequencies
GnomAD3 genomes AF: 0.000348 AC: 53AN: 152262Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000307 AC: 76AN: 247418Hom.: 0 AF XY: 0.000276 AC XY: 37AN XY: 134190
GnomAD4 exome AF: 0.000528 AC: 771AN: 1461098Hom.: 1 Cov.: 31 AF XY: 0.000479 AC XY: 348AN XY: 726792
GnomAD4 genome AF: 0.000348 AC: 53AN: 152380Hom.: 0 Cov.: 33 AF XY: 0.000242 AC XY: 18AN XY: 74512
ClinVar
Submissions by phenotype
INVS-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 03, 2024 | The INVS c.2056A>G variant is predicted to result in the amino acid substitution p.Arg686Gly. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.054% of alleles in individuals of Latino descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Nephronophthisis Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 25, 2022 | This sequence change replaces arginine, which is basic and polar, with glycine, which is neutral and non-polar, at codon 686 of the INVS protein (p.Arg686Gly). This variant is present in population databases (rs150001738, gnomAD 0.05%). This variant has not been reported in the literature in individuals affected with INVS-related conditions. ClinVar contains an entry for this variant (Variation ID: 500642). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jan 11, 2018 | - - |
Infantile nephronophthisis Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at